ClinicaliQ Trial Snapshot
- ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) — Recruiting • Gastroenterology • NCT04883905.
- Sponsor: Alnylam Pharmaceuticals.
Verify eligibility, endpoints and current status on the original source registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.
Eligibility Snapshot
- : * Documented diagnosis of AHP, per physician's determination
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.